This meeting took place in 2018

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Novel Aspects of Bone Biology (E3)

Organizer(s) Gerard Karsenty and David T. Scadden
June 13—16, 2018
Snowbird Resort • Snowbird, Utah USA
Discounted Abstract Deadline: Feb 27, 2018
Abstract Deadline: Mar 27, 2018
Scholarship Deadline: Feb 27, 2018
Discounted Registration Deadline: Apr 12, 2018

Supported by the Directors' Fund

Summary of Meeting:
This conference presents recent progress made in two relatively novel areas of skeletal biology not covered by other meetings. The first one is the cross-talk between bone, hematopoiesis and leukemogenesis. The second is the study of the various endocrine functions of bone and how their study impacts on our understanding of multiple degenerative diseases. Meetings of bone biology are traditionally dominated by the need to explain the basis and to propose treatments for the most frequent bone disease: osteoporosis. Aside from this very vivid field, these two other novel aspects of bone biology have developed in the last decade. A shared feature is that they link bone biology to multiple other organs and to other functions besides making bones. This conference showcases the many advances made in these two aspects of skeleton biology and how these developments have enriched our understanding of the pathogenesis of multiple degenerative diseases affecting the bone marrow, energy metabolism or the brain. Because of its very nature, this conference brings together investigators from different fields rarely afforded an opportunity to meet.

View Meeting Program


National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Scholarship Recipients

Annamaria Aprile
Ospedale San Raffaele SRL, Italy

Shawon Debnath
Weill Cornell Medicine, Cornell University, USA

Jaime Fornetti
Huntsman Cancer Institute, USA

Lori Khrimian
Regneron Pharmaceuticals, USA

Man K.S. Lee
Baker Heart & Diabetes Institute, Australia